Johnson, S. M., Vekeman, F., Luan, L., Hlavacek, P., Meche, A., Kim, C. H., Cislo, P., Aydin, D., Dibonaventura, M. (2025). Comparison of elranatamab's progression-free survival, duration of response, and overall survival from MagnetisMM-3 versus real-world external control arms: A subgroup analysis of China-predominant treatment regimens. Blood. https://doi.org/10.1182/blood-2025-8128